Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Aleksandra, Kukulska"'
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Heart failure (HF) is a chronic condition characterized by significant impairment of the cardiovascular system, leading to a decline in health-related quality of life, recurrent hospitalizations, and increased mortality risk. It p
Externí odkaz:
https://doaj.org/article/827b1b2382054dd8922e489a2099f486
Autor:
Jolanta Krajewska, Aleksandra Kukulska, Konrad Samborski, Agnieszka Czarniecka, Barbara Jarzab
Publikováno v:
Thyroid Research, Vol 16, Iss 1, Pp 1-13 (2023)
Abstract We have recently witnessed a rapid increase in the incidence of differentiated thyroid carcinoma (DTC), particularly low and very low-risk papillary thyroid carcinoma. Simultaneously, the number of cancer-related deaths has remained stable f
Externí odkaz:
https://doaj.org/article/1ed6dc26347a46c18dfb8f86d25e0751
Autor:
Aleksandra Kukulska, Jolanta Krajewska, Zofia Kołosza, Aleksandra Grządziel, Mateusz Gajek, Ewa Paliczka-Cieślik, Dorota Syguła, Kornelia Ficek, Aneta Kluczewska-Gałka, Barbara Jarząb
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract The role of radiotherapy in advanced medullary thyroid carcinoma (MTC) is confined to patients in whom surgical treatment or the administration of tyrosine kinase inhibitors are not possible or contraindicated. High fractionated radiation do
Externí odkaz:
https://doaj.org/article/c34ee7f800164c04bdb9ab70ac943254
Autor:
Aleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska, Ewa Paliczka-Cieslik, Daria Handkiewicz-Junak, Aleksandra Kropińska, Zbigniew Puch, Tomasz Olczyk, Jozef Roskosz, Barbara Jarzab
Publikováno v:
Archives of Medical Science, Vol 18, Iss 5, Pp 1241-1247 (2020)
Introduction The aim of this prospective study was to evaluate long-term outcomes in differentiated thyroid cancer (DTC) patients postoperatively treated with distinct RAI activities of 30 mCi, 60 mCi, and 100 mCi. Material and methods The analysis
Externí odkaz:
https://doaj.org/article/2a94c91ff63b4730b49446b03cf54a1b
Autor:
Aleksandra Kukulska, Jolanta Krajewska, Zofia Kolosza, Ewa Paliczka-Cieslik, Aleksandra Kropinska, Agnieszka Pawlaczek, Zbigniew Puch, Kornelia Ficek, Teresa Lisik, Dorota Sygula, Zbigniew Wygoda, Jozef Roskosz, Jerzy Wydmanski, Barbara Jarzab
Publikováno v:
Endocrine Connections, Vol 9, Iss 1, Pp 1-8 (2019)
The value of postoperative radiotherapy in the treatment of medullary thyroid carcinoma (MTC) has not been unequivocally demonstrated. Therefore our study aimed to answer the question of whether adjuvant radiotherapy showed any impact on the risk of
Externí odkaz:
https://doaj.org/article/3e5b1885cdcb4b15aa1de69bb0acc33d
Autor:
Jolanta Krajewska, Aleksandra Kukulska, Malgorzata Oczko-Wojciechowska, Agnieszka Kotecka-Blicharz, Katarzyna Drosik-Rutowicz, Malgorzata Haras-Gil, Barbara Jarzab, Daria Handkiewicz-Junak
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
We are witnessing a rapid worldwide increase in the incidence of papillary thyroid carcinoma (PTC) in the last thirty years. Extensive implementation of cancer screening and wide availability of neck ultrasound or other imaging studies is the main re
Externí odkaz:
https://doaj.org/article/b1606d4dc48d4519a9345f05fb74b1aa
Autor:
Barbara Jarząb, Marek Dedecjus, Andrzej Lewiński, Zbigniew Adamczewski, Elwira Bakuła-Zalewska, Agata Bałdys-Waligórska, Marcin Barczyński, Magdalena Biskup-Frużyńska, Barbara Bobek-Billewicz, Artur Bossowski, Monika Buziak-Bereza, Ewa Chmielik, Agnieszka Czarniecka, Rafał Czepczyński, Jarosław Ćwikła, Katarzyna Dobruch-Sobczak, Janusz Dzięcioł, Aneta Gawlik, Jacek Gawrychowski, Daria Handkiewicz-Junak, Jerzy Harasymczuk, Alicja Hubalewska-Dydejczyk, Joanna Januszkiewicz-Caulier, Michał Jarząb, Krzysztof Kaczka, Michał Kalemba, Grzegorz Kamiński, Małgorzata Karbownik-Lewińska, Andrzej Kawecki, Aneta Kluczewska-Gałka, Agnieszka Kolasińska-Ćwikła, Magdalena Kołton, Aleksander Konturek, Beata Kos-Kudła, Agnieszka Kotecka-Blicharz, Aldona Kowalska, Jolanta Krajewska, Andrzej Kram, Leszek Królicki, Aleksandra Kukulska, Michał Kusiński, Krzysztof Kuzdak, Dariusz Lange, Aleksandra Ledwon, Ewa Małecka‑Tendera, Przemysław Mańkowski, Bartosz Migda, Marek Niedziela, Małgorzata Oczko-Wojciechowska, Dariusz Polnik, Lech Pomorski, Marek Ruchała, Konrad Samborski, Anna Skowrońska-Szcześniak, Agata Stanek-Widera, Ewa Stobiecka, Zoran Stojčev, Magdalena Suchorzepka-Simek, Anhelli Syrenicz, Ewelina Szczepanek-Parulska, Małgorzata Trofimiuk‑Müldner, Andrzej Tysarowski, Andrzej Wygoda, Klaudia Zajkowska, Ewa Zembala-Nożyńska, Agnieszka Żyłka
Publikováno v:
Endokrynologia Polska. 73:173-300
The guidelines Thyroid Cancer 2022 are prepared based on previous Polish recommendations updated in 2018. They consider international guidelines - American Thyroid Association (ATA) 2015 and National Comprehensive Cancer Network (NCCN); however, they
Publikováno v:
Expert Review of Precision Medicine and Drug Development. 6:307-315
The discovery of a pivotal role of tyrosine kinases in the pathogenesis of medullary thyroid carcinoma (MTC) opened up new options in the systemic treatment of advanced disease. During the last dec...
Autor:
Jerzy Wydmanski, Dorota Syguła, Ewa Paliczka-Cieslik, Agnieszka Pawlaczek, Teresa Lisik, Zbigniew Wygoda, Józef Roskosz, Zofia Kolosza, Jolanta Krajewska, Barbara Jarzab, K. Ficek, Aleksandra Kukulska, Zbigniew Puch, Aleksandra Kropińska
Publikováno v:
Endocrine Connections, Vol 9, Iss 1, Pp 1-8 (2019)
The value of postoperative radiotherapy in the treatment of medullary thyroid carcinoma (MTC) has not been unequivocally demonstrated. Therefore our study aimed to answer the question of whether adjuvant radiotherapy showed any impact on the risk of
Autor:
Agnieszka Czarniecka, Zbigniew Wygoda, Józef Roskosz, Ewa Paliczka-Cieslik, Daria Handkiewicz-Junak, Jolanta Krajewska, Michal Jarzab, Zbigniew Puch, Barbara Jarzab, Aleksandra Kropińska, Aleksandra Król, Aleksandra Kukulska
Publikováno v:
Nuclear Medicine and Molecular Imaging
Purpose Although postoperative radioiodine (RAI) therapy has been used in patients with differentiated thyroid carcinoma (DTC) for many years, there is still lack of data defining the timing of RAI administration. A retrospective analysis was carried